AgriMetis Expands by Adding to Business Development Team
LUTHERVILLE, MD - May 21, 2018 – AgriMetis, LLC is pleased to announce that Brian Ember, PhD, MBA has joined the company as its Senior Director of Business Development. Dr. Ember will be a member of the AgriMetis management team and will lead the business aspects of AgriMetis’ pipeline and product development. He will also lead the company’s efforts in market and competitive intelligence.
Dr. Ember comes to AgriMetis with over a decade of experience in the biotechnology and agrochemical industries, spanning R&D and commercial business development. In his most recent role, Dr. Ember was instrumental in the commercialization of several novel crop protection products for a multinational agrichemical company.
“AgriMetis has built a strong product research and development program and team. We are excited to have Brian adding focus on business development while also bringing significant agrichemical experience to our team,” said Steven Tuttle, AgriMetis’ President and CEO.
Mr. Tuttle continued, “AgriMetis exploits the interface of biology, biochemistry, and chemistry to access areas of chemical space and production routes that are not available to others. AgriMetis’ approach requires creative, collaborative, and skilled business development, and Brian has a proven track record that can contribute to this effort.”
In an evolving and growing global population, there continues to be an increasing demand for sustainable, crop protection products. AgriMetis is committed to working with leading agriculture companies and businesses to fill this emerging need.
Our mission is to innovate sustainable crop protection products through leading edge and advanced discovery, development and delivery methods.
The AgriMetis technology platform is at the interface of biology, biochemistry, and chemistry. AgriMetis’ scientific approach is multidisciplinary and integrated, which allows AgriMetis to exploit areas of chemical space and production routes that are inaccessible to others.
AgriMetis was formed in March 2014 and completed a Series B financing in December 2016 to fund agriculture chemical research and development by applying a biopharmaceutical model. With headquarters near Baltimore, Maryland, AgriMetis continues to grow and develop its technologies and capabilities.
For more information, please visit our website at http://www.agrimetis.com.
This press release contains “forward-looking statements” concerning the development of AgriMetis’ products, the potential benefits and attributes of such products, and the company’s expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. AgriMetis undertakes no obligation to update any forward-looking statements for any reason.